23 Rucaparib was approved by the FDA in 2020 based on a recent clinical study, which involved 78 mCRPC patients with DNA repair gene alterations, including ATM ( n = 49), CDK12 ( n = 15), CHEK2 ( n = 12), and other genes ( n = 14)
The distributor, manufacturer, and seller of this product disclaim any responsibility for its misuse or any resulting consequences
The peels penetrate the skin and exfoliate the damaged, tanned layer of the skin
Known for boosting collagen, repairing skin, and restoring youthful energy, this copper peptide is redefining anti-aging care
Your consultation, follow-up care, and prescription management are completed through secure telehealth without any in-person appointments
61%) [Figure 12.1]